ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Vickers Vantage Corporation I

Vickers Vantage Corporation I (VCKA)

9.01
0.00
(0.00%)
Cerrado 27 Noviembre 3:00PM
0.00
0.00
(0.00%)
Fuera de horario: -

Su centro para precios en tiempo real, ideas y debates en vivo

Estadísticas y detalles clave

Último Precio
9.01
Postura de Compra
10.20
Postura de Venta
10.38
Volume Operado de la Acción
-
0.00 Rango del Día 0.00
0.00 Rango de 52 semanas 0.00
Capitalización de Mercado [m]
Precio Anterior
9.01
Precio de Apertura
-
Hora
Última hora de negociación
-
Volumen financiero
-
Precio Promedio Ponderado
-
Volumen promedio (3 m)
-
Acciones en circulación
155,943,000
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
-0.87
Beneficio por acción (BPA)
-0.73
turnover
46.74M
Beneficio neto
-114.33M

Acerca de Vickers Vantage Corporation I

Vickers Vantage Corp I is a blank check company. Vickers Vantage Corp I is a blank check company.

Sector
Biological Pds,ex Diagnstics
Industria
Biological Pds,ex Diagnstics
Sede
Wilmington, Delaware, USA
Fundado
-

VCKA Últimas noticias

Scilex Holding Company (“Scilex”), a Sorrento Company (nearly 100% or over 99.9% majority-owned subsidiary of Sorrento Therapeutics, Inc.) (Nasdaq: SRNE, “Sorrento”), and Vickers Vantage Corp. I Announce Effectiveness of Registration Statement on F

SEC declared Effectiveness of Vickers’s registration statement on Form S-4Extraordinary General Meeting of Vickers Vantage Corp. I shareholders to approve the proposed Business Combination is...

Scilex Holding Company, a Sorrento Company, Announces That the FDA Has Granted Fast Track Designation for SP-103 (Lidocaine Topical System) 5.4%, Next Generation Triple Strength Formulation of ZTlido®, for the Treatment of Acute Low Back Pain (LBP)

SP-103 receives Fast Track Designation, which makes it eligible for some or all of the following: More frequent meetings or written communication with the FDA to discuss the SP-103 development...

Scilex Holding Company, a Sorrento Company, Announces Exclusive Product Distribution Agreement with CH Trading Group LLC to Expand Commercialization of ZTlido® across certain designated territories including Middle East and North Africa

PALO ALTO, Calif., Aug. 17, 2022 (GLOBE NEWSWIRE) -- Scilex Holding Company (“Scilex”), a commercial biopharmaceutical company focused on developing and commercializing non-opioid therapies for...

Scilex Holding Company, a Sorrento Company, Announces Expanding Coverage to 30 Million Lives And Will Continue To Work To Access An Additional 20 Million Lives With One Of The Largest National Pharmacy Benefit Managers (PBMs) For ZTlido® (lidocaine topica

30 million lives now covered by one of the largest national PBMsContinue to work with this PBM to access an additional 20 million livesThe team continues to work with the national PBM’s and health...

Scilex Holding Company, a Sorrento Company, Has Entered A Term Sheet to Acquire Ancora Medical Inc.

Ancora Medical Inc. (“Ancora”) is a privately held medical technology company with an FDA approved product in February 2020, the Nerve Block Catheter Set which is indicated for surgical pain...

Scilex Holding Company, a Sorrento Company, announces that the Honorable Tommy G. Thompson has joined the Scilex Board of Directors

PALO ALTO, Calif., July 05, 2022 (GLOBE NEWSWIRE) -- Scilex Holding Company (“Scilex”), a nearly 100% (or over 99.9%) majority-owned subsidiary of Sorrento Therapeutics, Inc. (Nasdaq: SRNE...

Scilex Holding Company, a Sorrento Company, enters into an agreement for an exclusive license with ROMEG Therapeutics, LLC, for the right to commercialize Gloperba®, an FDA-approved prophylactic treatment for painful gout flares in adults, in the US.

Gloperba is an FDA-approved, oral medication for treating painful gout flares in adults.Gout is a painful arthritic disorder affecting an estimated 8.7 million people in the United States1. As...

Scilex Holding Company, a Sorrento Company, Announces Pre-Emptive Repurchase of $41.4 Million of its Senior Secured Notes

SAN DIEGO and PALO ALTO, Calif., June 03, 2022 (GLOBE NEWSWIRE) -- Scilex Holding Company (“Scilex”), a nearly 100% (or over 99.9%) majority-owned subsidiary of Sorrento Therapeutics, Inc...

Scilex, a Sorrento Company, Announces Initiation of a Phase 2 Study to Evaluate the Safety and Efficacy of SP-103 in Subjects with Acute Low Back Pain

Dosing of the first subject in a Phase 2, randomized, double-blind, placebo-controlled, parallel group, multicenter study to evaluate the safety and efficacy of SP-103 (lidocaine topical system...

Scilex Holding Company, a Sorrento Company, and Vickers Vantage Corp. I announced today the filing of a Registration Statement on Form S-4 with the Securities and Exchange Commission relating to the previously announced proposed business combination betwee

PALO ALTO, Calif. and NEW YORK, May 16, 2022 (GLOBE NEWSWIRE) -- Scilex Holding Company (“Scilex”), a Sorrento Company (nearly 100% or over 99.9% majority-owned subsidiary of Sorrento...

Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
AALAmerican Airlines Group Inc
US$ 14.64
(0.00%)
0
AAGRAfrican Agriculture Holdings Inc
US$ 0.1326
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
US$ 67.66
(0.00%)
0
AADIAadi Bioscience Inc
US$ 2.31
(0.00%)
0
AACGATA Creativity Global
US$ 1.02
(0.00%)
0
AALAmerican Airlines Group Inc
US$ 14.64
(0.00%)
0
AAGRAfrican Agriculture Holdings Inc
US$ 0.1326
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
US$ 67.66
(0.00%)
0
AADIAadi Bioscience Inc
US$ 2.31
(0.00%)
0
AACGATA Creativity Global
US$ 1.02
(0.00%)
0
AALAmerican Airlines Group Inc
US$ 14.64
(0.00%)
0
AAGRAfrican Agriculture Holdings Inc
US$ 0.1326
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
US$ 67.66
(0.00%)
0
AADIAadi Bioscience Inc
US$ 2.31
(0.00%)
0
AACGATA Creativity Global
US$ 1.02
(0.00%)
0
TRUSTUNITS1000000 TRUSTUNITS1000000 4 minutos hace
Wonder????? How longer
FMNJ
TRUSTUNITS1000000 TRUSTUNITS1000000 5 minutos hace
Terrible if another reverse split
FMNJ
TRUSTUNITS1000000 TRUSTUNITS1000000 5 minutos hace
12 more ticks
FMNJ
TRUSTUNITS1000000 TRUSTUNITS1000000 6 minutos hace
0.0012
FMNJ
TRUSTUNITS1000000 TRUSTUNITS1000000 6 minutos hace
Great share structure
DCMDF
TRUSTUNITS1000000 TRUSTUNITS1000000 6 minutos hace
Down 0.04
DCMDF
TRUSTUNITS1000000 TRUSTUNITS1000000 10 minutos hace
When trading again
TRUSTUNITS1000000 TRUSTUNITS1000000 11 minutos hace
Moller.com MLER, search on internet freedom motors engine
TRUSTUNITS1000000 TRUSTUNITS1000000 14 minutos hace
INDR
INDR
DiamondHealer95 DiamondHealer95 16 minutos hace
OH HERE IT IS! THE RANDOM "THE PRICE SHOULD BE" POST!

Definitely listen to this poster! They know what they're talking about!

What strikes me as odd is the timing! The stock has pumped and dumped one sent recently and all of a sudden we're getting people with price pre
KBLB
edbi46 edbi46 16 minutos hace
Lets see how high our beloved BIEL gets TRUMPed/JFK JUNIORed/DR. OZed up by Jan. 1, before NOPAIN Act is activated ( and, specifically, after!!! ) !!! HEHEHE.

ATTENTION all the Respected, Smart, Intelligent Investors !!!!!!! Do your OWN, INTELLIGENT, THOROUGH DD, without ANY INFLUENCE
MCF WBA
Viking61 Viking61 28 minutos hace
It also states that we have a chance to fix it the right way. GLTA
FNMA
stocksrising stocksrising 29 minutos hace
Ahhh, the good ole’ days when we could all talk about the benefits of Daxxy vs. competition ( and the claims and marketing on social media) …if deal closes, all a moot point, but if not, Revance could really take advantage of others missteps( assuming new leadership @ helm)

https://w
RVNC
NioTurd NioTurd 31 minutos hace
Let's play game... How much % lower are we going today?
I start : -4% (sarcastic)
NB
DMC8 DMC8 34 minutos hace
API supply orders as of Oct 04, 2024.
https://www.seair.co.in/us-import/i-amarin-pharma.aspx
API
Seminole Red Seminole Red 38 minutos hace
Biden Administration Awards $6.6 Billion Loan to EV Maker Accused of Defrauding Investors

“This $6 billion taxpayer-backed loan to Rivian is a glaring example of corporate welfare disguised as clean energy investment,” said American Energy Institute CEO Jason Isaac.

htt
fuagf fuagf 42 minutos hace
OMOLIVES, Now post some of Boebert's best, Jewish space
lasers was one? And MTG. That of yours was very weak.
Jimmy Joe Jimmy Joe 42 minutos hace
Awwwwww poor Bubbles. LMAO~!

Is Elite doing too well for ya~?

🩳y
ELTP
fuagf fuagf 49 minutos hace
dbergh, Doesn't surprise at all you would have downplayed it as Trump
did. You likely may have suggested trying drinking disinfectant too.
fuagf fuagf 59 minutos hace
OMOLIVES, Still you used it. To the bits you picked there. The first

"Start with Mitch McConnell and Senate Republicans in 2021. They could — and should — have voted to convict Trump after his second impeachment, which would have prevented him from running again for the presidency
Bob Mullet Bob Mullet 1 hora hace
Your opinions are garbage 
Still spamming the board?
People laugh at you 
Keep it up!!👍🏻 
KBLB
Truth_is_a_tool Truth_is_a_tool 1 hora hace
“” quit spamming the board “
She thinks she’s accomplishing a profound feat with her googling 🤣🤣🤣.
KBLB